# Marketaxess Holdings Inc: overview

MKTX · Nasdaq · CIK 1278021 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mktx.md) · [Financials](/companies/mktx/financials.md) · [Filings](/companies/mktx/filings.md) · [Insiders](/companies/mktx/insiders.md)

Latest reported revenue: [$218.4m](/filings/0001193125-26-340249.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-340249).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [207](/filings/0001193125-25-272335.md) | [202 d](/filings/0001193125-26-067009.md) | [209](/filings/0001193125-26-212081.md) | [219](/filings/0001193125-26-340249.md) | [209](/filings/0001193125-25-272335.md) | [209 d](/filings/0001193125-26-067009.md) | [233](/filings/0001193125-26-212081.md) | [218](/filings/0001193125-26-340249.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [42.1%](/filings/0001193125-25-272335.md) | [39.5% d](/filings/0001193125-26-067009.md) | [42.4%](/filings/0001193125-26-212081.md) | [41.9%](/filings/0001193125-26-340249.md) | [41.0%](/filings/0001193125-25-272335.md) | [36.3% d](/filings/0001193125-26-067009.md) | [43.2%](/filings/0001193125-26-212081.md) | [41.1%](/filings/0001193125-26-340249.md) |
| Net margin | % | [34.6%](/filings/0001193125-25-272335.md) | [32.2% d](/filings/0001193125-26-067009.md) | [7.2%](/filings/0001193125-26-340249.md) | [32.4%](/filings/0001193125-26-340249.md) | [32.6%](/filings/0001193125-25-272335.md) | [44.0% d](/filings/0001193125-26-067009.md) | [33.4%](/filings/0001193125-26-340249.md) | [31.2%](/filings/0001193125-26-340249.md) |
| Diluted EPS | $ per share | [1.90](/filings/0001193125-25-272335.md) | not reported | [0.40](/filings/0001193125-26-212081.md) | [1.91](/filings/0001193125-26-340249.md) | [1.84](/filings/0001193125-25-272335.md) | not reported | [2.20](/filings/0001193125-26-212081.md) | [1.93](/filings/0001193125-26-340249.md) |
| Free cash flow | $m | [94.3 d](/filings/0001193125-25-272335.md) | [176 d](/filings/0001193125-26-067009.md) | [27.7](/filings/0001193125-26-212081.md) | [103 d](/filings/0001193125-26-340249.md) | [88.7 d](/filings/0001193125-25-272335.md) | [155 d](/filings/0001193125-26-067009.md) | [(75.6)](/filings/0001193125-26-212081.md) | [26.2 d](/filings/0001193125-26-340249.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [699](/filings/0000950170-24-018935.md) | [718](/filings/0000950170-25-025606.md) | [753](/filings/0001193125-26-067009.md) | [817](/filings/0001193125-26-067009.md) | [846](/filings/0001193125-26-067009.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [48.2%](/filings/0000950170-24-018935.md) | [45.5%](/filings/0000950170-25-025606.md) | [41.9%](/filings/0001193125-26-067009.md) | [41.7%](/filings/0001193125-26-067009.md) | [40.4%](/filings/0001193125-26-067009.md) |
| Net margin | % | [36.9%](/filings/0000950170-24-018935.md) | [34.8%](/filings/0000950170-25-025606.md) | [34.3%](/filings/0001193125-26-067009.md) | [33.6%](/filings/0001193125-26-067009.md) | [29.1%](/filings/0001193125-26-067009.md) |
| Diluted EPS | $ per share | [6.77](/filings/0000950170-24-018935.md) | [6.65](/filings/0000950170-25-025606.md) | [6.85](/filings/0001193125-26-067009.md) | [7.28](/filings/0001193125-26-067009.md) | [6.64](/filings/0001193125-26-067009.md) |
| Free cash flow | $m | [265](/filings/0000950170-24-018935.md) | [276](/filings/0000950170-25-025606.md) | [324](/filings/0001193125-26-067009.md) | [375](/filings/0001193125-26-067009.md) | [374](/filings/0001193125-26-067009.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mktx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $453.9m | 3,999,836 |  | Reduced −75,318 |
| [PRIMECAP MANAGEMENT CO/CA/](/funds/763212.md) | 2026-06-30 | $397.8m | 3,504,905 |  | Added +157,780 |
| [North Reef Capital Management LP](/funds/1867831.md) | 2026-06-30 | $385.3m | 3,395,000 |  | Added +1,520,000 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $238.4m | 2,100,273 |  | Reduced −63,398 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $222.8m | 1,987,288 |  | Reduced −696,457 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $175.5m | 1,546,670 |  | Reduced −62,589 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $159.5m | 1,404,998 |  | Reduced −114,423 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $145.4m | 1,281,769 |  | Added +912 |
| [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $139.6m | 1,229,929 |  | Added +263,900 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $118.8m | 1,046,700 | Call | Added +928,500 |

## Recent filings

[All 1,171 filings](/companies/mktx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:22 ET | [8-K](/filings/0001193125-26-430472.md) | 8.01 Other events | 0001193125-26-430472 |
| 2026-10-23 | 06:30 ET | [8-K](/filings/0001193125-26-429420.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-429420 |
| 2026-10-22 | 13:21 ET | [8-K](/filings/0001193125-26-428689.md) | 8.01 Other events | 0001193125-26-428689 |
| 2026-09-29 | 17:24 ET | [8-K](/filings/0001193125-26-407834.md) | 8.01 Other events | 0001193125-26-407834 |
| 2026-08-07 | 16:10 ET | [10-Q](/filings/0001193125-26-340249.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340249 |
| 2026-07-30 | 07:50 ET | [8-K](/filings/0001193125-26-324950.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-324950 |
| 2026-07-30 | 07:44 ET | [8-K](/filings/0001193125-26-324933.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-324933 |
| 2026-06-10 | 16:15 ET | [8-K](/filings/0001193125-26-265854.md) | 5.07 Shareholder vote results | 0001193125-26-265854 |
| 2026-05-07 | 16:26 ET | [10-Q](/filings/0001193125-26-212081.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212081 |
| 2026-05-07 | 06:30 ET | [8-K](/filings/0001193125-26-210216.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-210216 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-067009.md), filed Feb 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1278021
- Tickers: MKTX
- Exchange: Nasdaq
- SIC code: 6211 Security Brokers, Dealers & Flotation Companies
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.